Related Experiment Video
Updated: Apr 26, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Insights from global data for use of rotavirus vaccines in India
T S Rao1, Rashmi Arora2, Ajay Khera3
1Department of Biotechnology, Ministry of Science and Technology, Government of India, CGO Complex, New Delhi, India.
Abstract:
Rotavirus vaccines are being introduced in several low- and middle-income countries across the world with and without support from the GAVI Alliance. India has the highest disease burden of rotavirus based on morbidity and mortality estimates and several indigenous vaccine manufacturers are developing rotavirus vaccines. One candidate has undergone phase III testing and others have completed evaluation in phase II. Global data on licensed vaccine performance in terms of impact on disease, strain diversity, safety and cost-effectiveness has been reviewed to provide a framework for decision making in India.
Related Concept Videos
Bacterial Gastroenteritis
Vaccinations
Vaccine Production
Vaccines
Viral Meningitis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

